173 related articles for article (PubMed ID: 12163714)
1. Biomarkers in cancer screening: a public health perspective.
Srivastava S; Gopal-Srivastava R
J Nutr; 2002 Aug; 132(8 Suppl):2471S-2475S. PubMed ID: 12163714
[TBL] [Abstract][Full Text] [Related]
2. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
3. A favorable view: progress in cancer prevention and screening.
Greenwald P
Recent Results Cancer Res; 2007; 174():3-17. PubMed ID: 17302181
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics: biomarkers of early detection.
Crichton DJ; Mattmann CA; Thornquist M; Anton K; Hughes JS
Cancer Biomark; 2010; 9(1-6):511-30. PubMed ID: 22112493
[TBL] [Abstract][Full Text] [Related]
5. The early detection research network: 10-year outlook.
Srivastava S
Clin Chem; 2013 Jan; 59(1):60-7. PubMed ID: 23160065
[TBL] [Abstract][Full Text] [Related]
6. Trends in biomarker research for cancer detection.
Srinivas PR; Kramer BS; Srivastava S
Lancet Oncol; 2001 Nov; 2(11):698-704. PubMed ID: 11902541
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
[TBL] [Abstract][Full Text] [Related]
8. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers.
Srivastava S; Wagner PD
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2401-2410. PubMed ID: 32357955
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
10. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
11. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
12. [Reform of Japan's NTP and its technical perspectives].
Mori T
Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
15. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives.
Mordente A; Meucci E; Martorana GE; Silvestrini A
Adv Exp Med Biol; 2015; 867():9-26. PubMed ID: 26530357
[TBL] [Abstract][Full Text] [Related]
16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
17. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.
Boja ES; Rodriguez H
Korean J Lab Med; 2011 Apr; 31(2):61-71. PubMed ID: 21474978
[TBL] [Abstract][Full Text] [Related]
18. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
19. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
